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Background  and  objectives:  Induction  of  anesthesia  is  a  critical  part  of  anesthesia  practice.
Sudden hypotension,  arrhythmias,  and  cardiovascular  collapse  are  threatening  complications
following injection  of  induction  agent  in  hemodynamically  unstable  patients.  It  is  desirable  to
use a  safe  agent  with  fewer  adverse  effects  for  this  purpose.  Present  prospective  randomized
study is  designed  to  compare  propofol  and  etomidate  for  their  effect  on  hemodynamics  and
various adverse  effects  on  patients  in  general  anesthesia.
Methods:  Hundred  ASA  I  and  II  patients  of  age  group  18--60  years  scheduled  for  elective  surgical
procedure  under  general  anesthesia  were  randomly  divided  into  two  groups  of  50  each  receiv-
ing propofol  (2  mg/kg)  and  etomidate  (0.3  mg/kg)  as  an  induction  agent.  Vital  parameters  at
induction,  laryngoscopy  and  thereafter  recorded  for  comparison.  Adverse  effect  viz.  pain  on
injection, apnea  and  myoclonus  were  carefully  watched.
Results:  Demographic  variables  were  comparable  in  both  the  groups.  Patients  in  etomidate
group showed  little  change  in  mean  arterial  pressure  (MAP)  and  heart  rate  (HR)  compared  to
propofol  (p  >  0.05)  from  baseline  value.  Pain  on  injection  was  more  in  propofol  group  while
myoclonus  activity  was  higher  in  etomidate  group.
Conclusions:  This  study  concludes  that  etomidate  is  a  better  agent  for  induction  than  propofol
in view  of  hemodynamic  stability  and  less  pain  on  injection.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
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injec¸ão  de  agente  de  induc¸ão  em  pacientes  hemodinamicamente  instáveis.  É  aconselhável  o
uso de  um  agente  seguro  com  menos  efeitos  adversos  para  esse  propósito.  O  presente  estudo
prospectivo,  randômico  teve  como  objetivo  comparar  propofol  e  etomidato  quanto  a  seus
efeitos sobre  a  hemodinâmica  e  aos  vários  efeitos  adversos  em  pacientes  sob  anestesia  geral.
Métodos:  Cem  pacientes  ASA  I  e  II,  idades  entre  18-60  anos,  programados  para  procedi-
mento cirúrgico  eletivo  sob  anestesia  geral  foram  divididos  aleatoriamente  em  dois  grupos
de 50  cada  para  receber  propofol  (2  mg/kg)  e  etomidato  (0,3  mg/kg)  como  um  agente  de
induc¸ão. Os  parâmetros  vitais  na  induc¸ão,  laringoscopia  e  posteriormente  foram  registrados
para comparac¸ão.  Efeitos  adversos  como  dor  à  injec¸ão,  apneia  e  mioclonia  foram  cuidadosa-
mente monitorados.
Resultados:  As  variáveis  demográﬁcas  foram  comparáveis  em  ambos  os  grupos.  Os  pacientes  do
grupo etomidato  apresentaram  pouca  alterac¸ão  da  pressão  arterial  média  (PAM)  e  da  frequência
cardíaca  (FC)  em  comparac¸ão  com  o  grupo  propofol  (p  <  0,05)  a  partir  do  valor  basal.  Houve
mais dor  à  injec¸ão  no  grupo  propofol,  enquanto  houve  mais  atividade  mioclônica  no  grupo
etomidato.
Conclusões:  Este  estudo  conclui  que  etomidato  é  um  agente  melhor  para  a  induc¸ão  que  propofol
em relac¸ão  à  estabilidade  hemodinâmica  e  menos  dor  à  injec¸ão.


























































nduction  agents  are  drugs  that,  when  given  intravenously
n  an  appropriate  dose,  cause  a  rapid  loss  of  consciousness.
nduction  agents  are  used  to  induce  anesthesia  prior  to  other
rugs  being  given  to  maintain  anesthesia,  as  the  sole  drug  for
hort  procedures,  to  maintain  anesthesia  for  longer  proce-
ures  by  intravenous  infusion,  to  provide  conscious  sedation
uring  procedures  undergoing  in  local  anesthesia  and  inten-
ive  care  unit.
Propofol,  2,6-diisopropylphenol  is  most  popular  induc-
ion  agent  with  its  favourble  characteristics  of  rapid  and
mooth  induction  and  recovery,  decrease  incidence  of  nau-
ea  and  vomiting,  etc.1,2 While  on  other  side  decrease  blood
ressure,  dose  dependent  depression  of  ventilation,  pain  on
njection  are  the  major  drawbacks.3--5
Etomidate,  carboxylated  imidazole  is  characterized  by
emodynamic  stability,  minimal  respiratory  depression  and
erebral  protective  effects.  Its  lack  of  effect  on  sympathetic
ervous  system,  baroreceptor  reﬂex  regulatory  system  and
ts  effect  of  increased  coronary  perfusion  even  on  patients
ith  moderate  cardiac  dysfunction  makes  it  an  induction
gent  of  choice  in  cardiac  disease  patients.6--9 However,  the
dverse  effects  such  as  pain  on  injection,  thrombophlebitis
nd  myoclonus  are  some  undesirable  adverse  effects.10,11
This  study  is  an  attempt  to  evaluate  the  effects  of  propo-
ol  and  etomidate  by  comparing  certain  parameters  such  as
hange  in  blood  pressure  and  heart  rate  during  induction
nd  intubation  as  a  primary  outcome  and  pain  an  injection,
yoclonic  movements,  Post-operative  nausea  and  vomiting
s  a  secondary  outcome;  so  that  we  can  choose  a  safer
nduction  agent.ethods
his  prospective  randomized  double  blind  study  is  conducted




pASA)  grade  I  and  II  between  18  and  60  years  of  age  of  either
ex,  scheduled  for  elective  surgical  procedure  under  general
nesthesia  with  endotracheal  intubation.
After  approval  from  institutional  ethical  committee,
ritten  informed  consent  was  obtained  from  all  the
atients.  The  total  100  patients  were  randomly  assigned
nto  2  groups  of  50  patients  each  according  to  a  computer
enerated  table  of  random  numbers.
 Group  I (n  =  50):  received  Inj.  Propofol  1%  (2  mg/kg  of  body
weight)
 Group  II  (n  =  50):  received  Inj.  Etomidate  (0.3  mg/kg  of
body  weight)
Patients  with  history  of  allergy  to  study  drugs,  history  of
eizure  disorder,  presence  of  primary  and  secondary  steroid
eﬁciency/on  steroid  medication  and  hypotensive  patients
ere  excluded  from  study.
All  patients  were  pre-medicated  with  tablets  alprazolam
.25  mg  and  ranitidine  150  mg,  the  night  before  the  surgery
nd  instructed  for  fasting  for  8  h.  On  arrival  at  operation
heatre,  patients  were  attached  with  standard  anesthesia
onitoring  including  Electrocardiogram  (ECG),  Non-invasive
lood  pressure  (NIBP),  Pulse  oximeter  and  baseline  vital
arameters  were  recorded.  An  18G  intravenous  (I.V.)  can-
ula  was  secured  in  left  hand  and  ringer  lactate  10  mL/kg/h
as  started.
Glycopyrrolate  0.2  mg,  midazolam  0.02  mg/kg  and
entanyl  3  mg/kg  I.V.  were  injected  followed  by  an  induc-
ion  dose  of  either  propofol  (Propofol  spiva  1%,  Claris
ifesciences  Limited)  or  etomidate  (Etomidate  Lipuro,  B.
raun,  India).  Pain  on  injection  and  myoclonic  movements
ere  recorded,  if  any  at  induction.  Trachea  was  intubated
ith  appropriate  size  of  endotracheal  tube  after  3  min  of
ntubating  dose  of  vecuronium  (0.1  mg/kg)  I.V.  Endotracheal
ube  was  secured  after  conﬁrming  correct  position  and
ositive  pressure  ventilation  was  initiated.  Anesthesia






100 patients were recruited
Propofol (2mg/kg) Etomidate (0.3mg/kg)
n=50
116 patients assessed for eligibility Table  1  Demographic  characteristic  of  patients  (p  >  0.05).
Variable  Group  I  Group  II
Sex  (female:male)  30:20  27:23
Age (years)  mean  ±  SD  29.16  ±  11.38  27.86  ±  10.09
Weight  (kg)  mean  ±  SD  56.02  ±  11.03  57.4  ±  11.16
ASA grade  I/II  26/24  23/27
Baseline At induction At 
Laryngoscopy









Figure  2  Showing  MAP  at  different  time  intervals.  A  signiﬁ-
cant decrease  in  MAP  from  baseline  at  induction  with  propofol
in compare  to  etomidate  is  observed  (p  >  0.05),  there  after  MAP




























Group I Group II
Figure  3  Showing  HR  at  different  time  intervals.  Increase  in





myoclonus  was  noted  as  grade  1  (20%),  grade  2  (14%)  and
grade  3  (2%)  (Table  4).
Table  2  Incidence  and  grading  of  pain  on  injection.
Group  Pain  on  injection  p-Valuen=50
Figure  1  Study  design.
was  maintained  with  oxygen  and  nitrous  oxide  (70:30)  in
isoﬂurane  along  with  intermittent  boluses  of  vecuronium,
as  required  throughout  the  surgery.  At  the  end  of  surgery,
the  residual  neuromuscular  block  was  antagonized  with
neostigmine  (0.05  mg/kg)  and  glycopyrrolate  (0.01  mg/kg)
I.V.  and  extubation  was  performed  when  respiration  was
adequate  and  patient  was  able  to  obey  verbal  commands.
Systolic  blood  pressure,  diastolic  blood  pressure,  mean
arterial  pressure,  heart  rate  were  continuously  monitored
and  recorded  before  induction,  at  induction  and  laryn-
goscopy  followed  by  1,  3,  5  and  10  minutes  after  intubation.
Pain  on  injection  was  measured  using  4  graded  scale;  0  --  no
pain,  1  --  verbal  complaint  of  pain,  2  --  withdrawal  of  arm,
3  -- both  verbal  complaint  and  withdrawal  of  arm.  The  inci-
dence  and  degree  of  myoclonic  movements  also  recorded  as
follows:  0 =  no  myoclonic  movements,  1  =  minor  myoclonic
movements,  2  =  moderate  myoclonic  movements,  3  =  major
myoclonic  movements.  Episode  of  apnea,  if  occurred  was
recorded.
Statistical  analysis
Data  are  presented  as  mean  ±  SD.  Patient  characteristic
data  were  analysed  with  one  way  ANOVA  for  continuous
variables  and  chi-square  test  for  categorical  variables.  Sta-
tistical  analysis  was  done  using  SPSS  20  (IBM  SPSS  Statistics).
p-Value  <0.05  was  considered  signiﬁcant.
Results
A  total  of  116  patients  were  assessed  for  eligibility  from
December  2013  to  May  2014,  out  of  which  16  patients  were
excluded  from  study  on  account  of  refusal  to  consent  (four-
teen  patients)  and  on  steroid  medications  (two  patients).
100  patients  were  completed  the  study  after  randomization
in  two  groups  (Fig.  1).
Both  groups  were  comparable  in  age,  sex,  weight  and
ASA  physical  status,  with  no  statistically  signiﬁcant  differ-
ences  (p  >  0.05)  (Table  1).  Pre-operative  vitals  (HR,  SBP,
DBP  and  MAP)  were  comparable  in  both  groups  with  no
statistically  signiﬁcant  differences  (p  >  0.05).  Decrease  in
MAP  and  increase  in  heart  rate  was  more  from  baseline  in
propofol  group  than  etomidate  group  at  induction  (p  >  0.05)
(Figs.  2  and  3).  Fifty  percent  of  patients  received  propofol
complained  pain  while  only  four  percent  patient  in  etomi-
date  group  (p  >  0.05).  Also,  the  severity  of  pain  was  more
with  propofol  (Table  2).  Incidence  of  apnea  was  similarropofol  group  (p  >  0.05),  then  became  comparable  to  etomi-
ate (p  >  0.05).
n  both  groups  (p  >  0.05)  (Table  3).  Myoclonic  movements
ere  only  seen  in  etomidate  group  (p  >  0.05).  Severity  ofGrade  0  Grade  1  Grade  2
Group  I 25  (50%)  16  (32%)  9  (18%)  0.002
Group  II  48  (96%)  2  (4%)  0  (0%)
240  
Table  3  Incidence  of  apnea  on  induction  in  both  groups.
Group  Apnea  on  induction  p-Value
Yes  No
Group  I  38  (76%)  12  (24%)  0.271
Group  II  33  (66%)  17  (34%)
Table  4  Incidence  of  myoclonic  movements  in  both  groups.
Myoclonic  movements  Group  I  Group  II  p-Value
Grade  0  50  (100%)  32  (64%)  0
Grade  1  0  (0%)  10  (20%)























































to propofol-mediated hypotension in humans. Anesth Analg.
1992;74:877--83.Grade  3  0  (0%)  1  (2%)
iscussion
nduction  of  anesthesia  is  associated  with  hemodynamic
ariation  of  mild  to  moderate  degree  depending  upon  many
actors.  In  our  study,  we  observed  that  propofol  caused
igniﬁcant  hypotension  and  tachycardia  at  induction  in  com-
arison  to  etomidate.  Hypotension  occurs  with  propofol
s  mainly  due  to  reduction  of  sympathetic  activity  caus-
ng  vasodilation  or  its  direct  effect  on  vascular  smooth
uscles.12,13 Sudden  hypotension  and  tachycardia  has  dele-
erious  effects  on  maintaining  the  circulation  to  vital  organs
n  patients  of  coronary  artery  disease,  valvular  stenosis,
ncontrolled  hypertension  and  shock.  On  another  side  hemo-
ynamic  stability  observed  with  etomidate  may  be  due  to  its
nique  lack  of  effect  on  the  sympathetic  nervous  system  and
n  baroreceptor  functions.14,15 Mayer  et  al.16 and  Wu  et  al.17
lso  concluded  that  etomidate  preserve  hemodynamic  sta-
ility  during  anesthesia.
Etomidate  does  not  have  its  limitation  to  normotensive
atients  for  its  hemodynamic  peculiarity.  In  various  stud-
es,  etomidate  shown  less  cardiovascular  depression  and
inimize  use  of  vasopressor  agents  than  other  induction
gent  in  sepsis  and  critically  ill  patients.  Although  eto-
idate  can  cause  adrenal  insufﬁciency  in  these  patients
n  postoperative  period,  clinical  consequence  of  that  is
till  unclear  over  its  advantage  to  prevent  hypotension  at
nduction.18--21
Pain  during  injection  of  anesthetic  agent  is  a  bad  expe-
ience  for  patient  while  it  quite  embarrassing  situation  for
n  anesthesiologist.  Etomidate  shown  a  favourble  outcome
nd  it  was  very  well  supported  by  Saricaoglu  et  al.22 and
u  et  al.17 in  their  studies.  Both  agents  had  shown  simi-
arity  in  their  respiratory  depressant  effect.  The  episodes
f  apnea  were  transient  and  not  associated  with  any  fall
n  oxygen  saturation.  Boysen  et  al.23 in  their  study  con-
luded  that  there  was  no  signiﬁcant  difference  between
wo  groups  (propofol  and  etomidate)  as  regard  to  apnea
ollowing  induction.  The  only  negative  characteristic  noted
ith  etomidate  was  high  incidence  of  myoclonic  jerks.  Miner
t  al.24 was  also  concluded  high  incidence  of  myoclonus
20%  vs.  1.8%)  in  etomidate  and  propofol  group  respec-
ively.
1S.  Aggarwal  et  al.
onclusion
n  conclusion,  etomidate  is  better  for  its  hemodynamic  sta-
ility  over  propofol  along  with  less  incidence  of  pain  on
njection.  Only  drawback  was  high  incidence  of  myoclonus.
e  therefore  suggest  that  etomidate  is  a  better  option  in
atients  particularly  prone  to  hemodynamic  ﬂuctuation  at
nduction  like  uncontrolled  hypertension,  septic,  critically
ll  and  patients  with  coronary  artery  disease.
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